VARA
ORCL icon

Value Aligned Research Advisors’s Oracle ORCL Stock Holding History

Value Aligned Research Advisors’s Portfolio ORCL Stock Details ORCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$335M Buy
2,274,700
+1,756,600
+339% +$286M 1.62% 15
2025
Q4 		$101M Buy
518,100
+168,100
+48% +$40M 1.02% 31
2025
Q3 		$98.4M Buy
350,000
+53,700
+18% +$13.7M 1.2% 25
2025
Q2 		$64.8M Buy
296,300
+257,200
+658% +$41.5M 1.37% 19
2025
Q1 		$5.47M Buy
+39,100
New +$6.37M 0.4% 30

Other funds holding ORCL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Value Aligned Research Advisors's ORCL Position: Q1 2026 in Review

Value Aligned Research Advisors reduced its Oracle (ORCL) stake by 19% in Q1 2026, selling an estimated $4.28M and leaving 115,078 shares worth $16.9M. The position accounts for 0.08% of the portfolio, ranked #74.

Value Aligned Research Advisors first reported a position in ORCL in Q1 2025 and has held it in 3 quarters since. The position peaked at $27.6M in Q4 2025. 3,471 funds tracked by Wall St. Rank hold ORCL as of Q1 2026.

  • Value Aligned Research Advisors held 115,078 shares of Oracle worth $16.9M as of Q1 2026.
  • Value Aligned Research Advisors sold 26,331 Oracle shares in Q1 2026, an estimated $4.28M.
  • Oracle made up 0.08% of Value Aligned Research Advisors's portfolio in Q1 2026, its #74 holding.
  • Value Aligned Research Advisors first reported a position in Oracle in Q1 2025 and has held it in 3 quarters since.
  • Value Aligned Research Advisors's Oracle position peaked at $27.6M in Q4 2025.
  • 3,471 funds tracked by Wall St. Rank held Oracle as of Q1 2026.

Based on Value Aligned Research Advisors's 13F filing for Q1 2026, filed 18 May 2026.